Calcitonin gene relating peptide inhibitors in combination for migraine treatment: A mini-review

The discovery of calcitonin gene-related peptide (CGRP) and its role in migraine pathophysiology has led to advances in the treatment of migraine. Since 2018, the Food and Drug Administration (FDA) has approved four monoclonal antibody (mab) therapies targeting either the CGRP ligand or receptor and...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Tulsi, Bedrin, Kate, Tinsley, Amanda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pain Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064089/
https://www.ncbi.nlm.nih.gov/pubmed/37006413
http://dx.doi.org/10.3389/fpain.2023.1130239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064089/
https://www.ncbi.nlm.nih.gov/pubmed/37006413
http://dx.doi.org/10.3389/fpain.2023.1130239

Ejemplares similares